Arch Biopartners Inc

NEW
OTCPK:ACHFF (Canada)  
$ 1.24 (0%) 02:08 PM EST
At Loss
Market Cap:
$ 80.58M
Enterprise V:
$ 82.51M
Volume:
-
Avg Vol (2M):
6.56K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
-
At Loss
Avg Vol (2M):
6.56K

Business Description

Description
Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.
Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -7.98
Debt-to-Equity -0.66
Debt-to-EBITDA -2.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.11
Quick Ratio 0.11
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.4
Shareholder Yield % 0.95
Name Current Vs Industry Vs History
ROA % -160.72
ROIC % -34.61
3-Year ROIIC % -245.49

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -80.42
EV-to-EBITDA -80.42
EV-to-Forward-Revenue 50.96
EV-to-FCF -83.41
Earnings Yield (Greenblatt) % -1.24
FCF Yield % -1.26

Financials

ACHFF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:ACHFF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Arch Biopartners Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.017
Beta 1.82
3-Year Sharpe Ratio -0.21
3-Year Sortino Ratio -0.32
Volatility % 37.01
14-Day RSI 43.38
14-Day ATR ($) 0.030757
20-Day SMA ($) 1.27045
12-1 Month Momentum % -23.64
52-Week Range ($) 0.8925 - 1.791
Shares Outstanding (Mil) 65.86

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arch Biopartners Inc Filings

Filing Date Document Date Form
No Filing Data

Arch Biopartners Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Arch Biopartners Inc Frequently Asked Questions

What is Arch Biopartners Inc(ACHFF)'s stock price today?
The current price of ACHFF is $1.24. The 52 week high of ACHFF is $1.79 and 52 week low is $0.89.
When is next earnings date of Arch Biopartners Inc(ACHFF)?
The next earnings date of Arch Biopartners Inc(ACHFF) is .
Does Arch Biopartners Inc(ACHFF) pay dividends? If so, how much?
Arch Biopartners Inc(ACHFF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1